Biocept, Inc. – NASDAQ:BIOC
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 15 hours
Biocept stock price monthly change
-68.93%
month
Biocept stock price quarterly change
-78.57%
quarter
Biocept stock price yearly change
-41.14%
year
Biocept key metrics
Market Cap | N/A |
Enterprise value | N/A |
P/E | -0.36 |
EV/Sales | N/A |
EV/EBITDA | 0.01 |
Price/Sales | 0.10 |
Price/Book | 0.19 |
PEG ratio | N/A |
EPS | -58.34 |
Revenue | -3.43M |
EBITDA | -35.38M |
Income | -34.90M |
Revenue Q/Q | -94.44% |
Revenue Y/Y | -105.54% |
Profit margin | -35.09% |
Oper. margin | -34.33% |
Gross margin | 29.89% |
EBIT margin | -34.33% |
EBITDA margin | 1029.83% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBiocept stock price history
Biocept stock forecast
Biocept financial statements
| Sep 2022 | 5.58M | -5.51M | -98.68% |
|---|---|---|---|
| Dec 2022 | -10.28M | -18.52M | 180.09% |
| Mar 2023 | 673K | -7.23M | -1075.19% |
| Jun 2023 | 589K | -3.63M | -616.47% |
| 2022-05-23 | -0.14 | -0.16 |
|---|---|---|
| 2022-11-21 | -0.19 | -0.33 |
| Sep 2022 | 51102000 | 23.58M | 46.15% |
|---|---|---|---|
| Dec 2022 | 30873000 | 22.01M | 71.3% |
| Mar 2023 | 22993000 | 20.56M | 89.44% |
| Jun 2023 | 22103000 | 21.81M | 98.69% |
| Sep 2022 | -4.07M | -356K | -476K |
|---|---|---|---|
| Dec 2022 | -4.24M | -136K | -746K |
| Mar 2023 | -6.19M | -91K | 162K |
| Jun 2023 | -3.08M | -22K | 2.96M |
Biocept alternative data
| Aug 2023 | 50 |
|---|---|
| Sep 2023 | 50 |
| Oct 2023 | 50 |
| Nov 2023 | 50 |
| Dec 2023 | 50 |
| Jan 2024 | 50 |
| Feb 2024 | 50 |
| Mar 2024 | 50 |
| Apr 2024 | 50 |
| May 2024 | 50 |
| Jun 2024 | 50 |
| Jul 2024 | 50 |
Biocept other data
2.96%
-5.39%
of BIOC is owned by hedge funds
14
-11
502.28K
-917.57K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2021 | 0 | 445 |
| Patent |
|---|
Application Filling date: 15 Jul 2021 Issue date: 20 Jan 2022 |
Application Filling date: 13 Jul 2020 Issue date: 29 Oct 2020 |
Application Filling date: 26 Nov 2019 Issue date: 29 Oct 2020 |
Grant Filling date: 30 Oct 2017 Issue date: 18 Aug 2020 |
Grant Filling date: 29 Jul 2015 Issue date: 7 Jan 2020 |
Application Filling date: 10 Jul 2019 Issue date: 14 Nov 2019 |
Grant Filling date: 27 Jun 2016 Issue date: 6 Aug 2019 |
| Quarter | Transcript |
|---|---|
| Q3 2022 28 Nov 2022 | Q3 2022 Earnings Call Transcript |
| Q3 2021 15 Nov 2021 | Q3 2021 Earnings Call Transcript |
| Q2 2021 16 Aug 2021 | Q2 2021 Earnings Call Transcript |
| Q1 2021 12 May 2021 | Q1 2021 Earnings Call Transcript |
-
When is Biocept's next earnings date?
Unfortunately, Biocept's (BIOC) next earnings date is currently unknown.
-
Does Biocept pay dividends?
No, Biocept does not pay dividends.
-
What is Biocept's stock symbol?
Biocept, Inc. is traded on the NASDAQ under the ticker symbol "BIOC".
-
What is Biocept's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Biocept?
Shares of Biocept can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Biocept's key executives?
Biocept's management team includes the following people:
- Mr. Michael W. Nall Chief Executive Officer, Pres & Director(age: 62, pay: $739,580)
- Mr. Timothy C. Kennedy Chief Financial Officer, Chief Operating Officer & Corporation Sec.(age: 67, pay: $504,330)
- Mr. Michael Terry Senior Vice President of Corporation Devel.(age: 70, pay: $306,470)
-
How many employees does Biocept have?
As Jul 2024, Biocept employs 50 workers.
-
When Biocept went public?
Biocept, Inc. is publicly traded company for more then 11 years since IPO on 5 Feb 2014.
-
What is Biocept's official website?
The official website for Biocept is biocept.com.
-
Where are Biocept's headquarters?
Biocept is headquartered at 9955 Mesa Rim Road, San Diego, CA.
-
How can i contact Biocept?
Biocept's mailing address is 9955 Mesa Rim Road, San Diego, CA and company can be reached via phone at 858 320 8200.
Biocept company profile:
Biocept, Inc.
biocept.comExchange:
NASDAQ
Full time employees:
50
Industry:
Medical - Diagnostics & Research
Sector:
Healthcare
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The company offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), gastric cancer, colorectal cancer, prostate cancer, pancreaticobiliary cancer, and ovarian cancer. It also provides cerebrospinal fluid tumor cell and ctDNA and ctRNA testing services to medical oncologists, neuro-oncologists, surgical oncologists, urologists, pulmonologists, pathologists, and other physicians; clinical trial and research services to pharmaceutical companies, biopharmaceutical companies and clinical research organizations; and RT-PCR testing services for COVID-19. The company has a collaboration with CLEARED4 to develop a system for tracking and managing COVID-19 testing requirements and test results for its customers; and with Protean BioDiagnostics, Inc. to research the ability of its Target Selector molecular assay to determine EGFR status in NSCLC patients. Biocept, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
9955 Mesa Rim Road
San Diego, CA 92121
San Diego, CA 92121
CIK: 0001044378
ISIN: US09072V6002
CUSIP: 09072V402
